Page 2 - Score Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Healthcare major Abbott on Monday said it has launched a test that will help in the early detection of Hepatitis B virus HBV in human serum and plasma samples. The company has introduced HBsAg Next Qualitative solution to help improve patient outcomes while maintaining safe blood supplies. This highly sensitive chemiluminescent microparticle immunoassay CMIA assists in the early and enhanced detection of HBV in human serum and plasma blood samples and in population screening, Abbott said in a statement. In India, Hepatitis B screening is vital since it is vastly underdiagnosed.

AZoM spoke to David Anderson, a director at Score Diagnostics Ltd, about the role valve maintenance and diagnostics play in efforts to reduce emissions in the chemical industry and make industry as a whole greener.

/PRNewswire/ -- Doceree Inc, the first global network of physician-only platforms for programmatic messaging, today announced the completion of $11 million...

Healthtech startup Doceree has completed its $11 Mn Series A funding round led by Eight Roads Ventures, an investment firm backed by Fidelity.

Trends in Health sciences in 2021 & Prognosis for 2022